These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26286711)

  • 1. Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy.
    Lin YH; Chen ZR; Lai CH; Hsieh CH; Feng CL
    Biomacromolecules; 2015 Sep; 16(9):3021-32. PubMed ID: 26286711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
    Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
    ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
    Yuan X; He Y; Zhou G; Li X; Feng A; Zheng W
    J Photochem Photobiol B; 2018 Jun; 183():147-153. PubMed ID: 29705507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
    Dube A; Nicolazzo JA; Larson I
    Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery.
    Li W; Yalcin M; Lin Q; Ardawi MM; Mousa SA
    J Control Release; 2017 Feb; 248():117-124. PubMed ID: 28077264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.
    Hu B; Ting Y; Yang X; Tang W; Zeng X; Huang Q
    Chem Commun (Camb); 2012 Feb; 48(18):2421-3. PubMed ID: 22266839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
    Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
    Siddiqui IA; Bharali DJ; Nihal M; Adhami VM; Khan N; Chamcheu JC; Khan MI; Shabana S; Mousa SA; Mukhtar H
    Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
    Wu H; Xin Y; Xiao Y; Zhao J
    Cancer Biother Radiopharm; 2012 Apr; 27(3):204-9. PubMed ID: 22283637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dressing with epigallocatechin gallate nanoparticles for wound regeneration.
    Lin YH; Lin JH; Li TS; Wang SH; Yao CH; Chung WY; Ko TH
    Wound Repair Regen; 2016 Mar; 24(2):287-301. PubMed ID: 26472668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
    Jang MK; Jeong YI; Nah JW
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
    Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
    Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.
    Jana S; Maji N; Nayak AK; Sen KK; Basu SK
    Carbohydr Polym; 2013 Oct; 98(1):870-6. PubMed ID: 23987423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.
    Sun Z; Song X; Li X; Su T; Qi S; Qiao R; Wang F; Huan Y; Yang W; Wang J; Nie Y; Wu K; Gao M; Cao F
    Nanoscale; 2014 Nov; 6(23):14343-53. PubMed ID: 25327162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.